Top Brand Name Drug Companies Bank Sky-High Profits While Evading Accountability And that’s a wrap! Over three weeks of earnings calls have proven, yet again, that hiking prices is a profitable practice for an industry more concerned with pleasing its shareholders than helping patients. This quarter, CSRxP tracked earnings reports from 12 of the […]
Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Banked Sky-High Profits After Hiking Prices Earnings reports for the fourth quarter of 2019 provide the latest evidence that Big Pharma continues to bank sky-high profits while price-gouging American patients. Today, brand name drug giant AstraZeneca announced rising profits completing a trend that holds […]
Big Pharma Giant Bests Wall Street Expectations After Hiking Prices In January Yet another brand name drug company announced last week it had surpassed earnings expectations after hiking prices on American patients. On Friday, Big Pharma giant AbbVie reported sky-high profits after enacting a series of price hikes throughout 2019. AbbVie reported 4th quarter […]
Brand Name Drug Companies Keep the Good Times Rolling for Shareholders by Price-Gouging American Patients This week, three more Big Pharma giants proved yet again that hiking prices is a profitable practice for an industry more concerned with pleasing its shareholders than helping patients. Merck, GlaxoSmithKline (GSK) and Bristol-Myers Squibb all reported sky-high profits this […]
Testimony Highlights How Brand Name Drug Companies Use Nonprofits To Keep Prices High & Pad Their Bottom Line Expert witnesses at a Wednesday hearing before the U.S. House of Representatives Committee on Ways & Means Subcommittee on Health highlighted how Big Pharma exploits nonprofit charities as a vehicle to boost their bottom line. Ge Bai, […]
Pharmaceutical Companies to Blame for Out-of-Control Prices for Life-Saving Drug During tonight’s State of the Union address, President Trump is expected to address the mounting crisis of affordability caused by the out-of-control price of prescription drugs. One drug in particular has been at the forefront of this crisis for millions of Americans diagnosed with […]
Congressional Action Needed to Shine a Light on Big Pharma’s Egregious Pricing Tactics & Hold the Industry Accountable In yet another example of the lengths Big Pharma will go to evade responsibility and keep prices high, a new analysis from Bloomberg Law reveals that efforts to reign in out-of-control prescription drug prices on the state-level […]
Brand Name Drug Giant Beats Wall Street Expectations After Price Hikes on Treatments for Osteoporosis, Heart Conditions and Cancer Yet another Big Pharma giant proved what we already know – that hiking prices on American patients continues to be a profitable practice for the pharmaceutical industry. On Thursday, brand name drug company Amgen announced it […]
Brand Name Giants Keep Good Times Rolling Thanks to Series of Price Hikes on American Patients New fourth quarter earnings reports released this week from brand name giants Eli Lilly, Roche, Novartis and Pfizer demonstrate that out-of-control prescription drug prices paired with repeated price hikes continue to support big time profits for Big Pharma. All […]
Prescription Drug Price Hikes Help Fuel Massive 32 Percent Boost to Profits For Big Pharma Giant As millions of Americans struggle to afford the medications they need, the first earnings report from a Big Pharma giant demonstrates the industry continues to rake in sky-high profits by shamelessly hiking prices. Just yesterday, brand name drug […]